Back to BlogWhy Now

    Why Now? Market Validation is Here

    From Zero Revenue to ₹1,000 Cr Valuations: How Indian Deep Tech Companies Are Proving the Model Works

    10 February 202612-15 min read

    By Akti Ventures

    The Proof is in the Revenue

    For decades, 'Indian deep tech' was an oxymoron. India did software and services. Hardware, manufacturing, and deep R&D happened elsewhere. That narrative is dead.

    In the last 4 years (2020-2024), Indian deep tech companies went from prototypes to production scale, from zero revenue to ₹100-1,000+ Cr annual revenue, from local curiosity to global players. This isn't theory. This is market validation.

    The Scoreboard: Indian Deep Tech Companies at Scale

    Robotics: Addverb Technologies (founded 2016) — Revenue ₹1,000+ Cr, Valuation ₹4,000 Cr, customers include Reliance (₹1,000 Cr contract), Flipkart, Amazon India. Competing with Amazon Robotics, beating them 40% on cost. GreyOrange — Revenue $100M+ (₹800+ Cr), selling to Walmart, IKEA, DHL across 10+ countries.

    Defense: ideaForge (founded 2007) — Revenue ₹400+ Cr, Market Cap ₹2,800+ Cr (post-IPO 2023), 50%+ Indian military drone market share, exports to Middle East. First Indian drone company to IPO, beating Israeli/Chinese imports.

    Electric Vehicles: Ather Energy — Revenue ₹1,800+ Cr, 150,000+ units sold, 15% market share. Ola Electric — Revenue ₹5,000+ Cr, 400,000+ units (FY 2023-24), scaled from zero to 1M annual capacity in 4 years—faster than Tesla's early ramp.

    Space: Skyroot Aerospace — $68M raised, first private Indian rocket launch (Nov 2022). Agnikul Cosmos — $40M raised, world's first single-piece 3D-printed rocket engine. Pixxel — $71M raised, 3 satellites in orbit, contracts with NASA, ESA, ISRO.

    Clean Energy: Waaree Energies — Revenue ₹10,000+ Cr, 12 GW capacity, Market Cap ₹60,000+ Cr post-IPO. 40% revenue from exports competing with Chinese manufacturers globally.

    Biotech: Meril Life Sciences — Revenue ₹1,200+ Cr, cardiac stents exported to 100+ countries, replacing Abbott and Boston Scientific at 60% cost advantage.

    Five Proof Points of Validation

    Revenue at Scale: 15+ Indian deep tech companies crossed ₹100 Cr revenue (2023-24). 5 crossed ₹1,000 Cr. One customer is a pilot. 100 customers paying ₹100+ Cr annually is validation.

    Customer Diversification: ideaForge has 60% defense, 30% commercial, 10% export. Pixxel has 40% government (NASA, ISRO), 60% commercial. Top companies have 3+ customer segments—not dependent on a single buyer.

    Repeat Orders: Addverb's Reliance contract is ₹1,000 Cr over 5 years (recurring). ideaForge gets repeat Army orders every 6-12 months. Ather has 40% repeat customers. Repeat purchase rates of 30-50% for B2B deep tech.

    Margin Expansion: Meril at 55% gross margins (comparable to Abbott). GreyOrange at 50%+. Successful deep tech companies achieve 40-50% gross margins at scale proving cost discipline + pricing power.

    Global Competitive Wins: ideaForge drones beat Israeli drones in military tenders. Meril stents beat Abbott in 15-20% of India market. Addverb robots beat Amazon Robotics in Reliance tender. Skanray replacing GE/Philips in 200+ hospitals.

    The IPO Milestone: Public Market Validation

    ideaForge (Defense Drones, July 2023): Market Cap ₹2,800 Cr, 20-50% post-IPO gain. First Indian defense tech IPO—proved defense startups are investable. Waaree Energies (Solar, October 2024): Market Cap ₹60,000+ Cr, 60-100% post-IPO gain. Largest clean energy IPO in India.

    Ola Electric (EV, August 2024): Market Cap ₹40,000+ Cr. Validated Indian EV companies can scale to 1M+ units/year. Pipeline: Ather Energy IPO likely 2025, GreyOrange considering India listing, Meril discussions ongoing.

    What IPOs prove: Audited financials pass SEBI scrutiny. Institutional investors buy in—mutual funds and FIIs don't invest in science experiments. VCs who invested at ₹100-500 Cr exit at ₹3,000-60,000 Cr—deep tech generates VC-style returns.

    Export Validation: Selling Globally from India

    The highest form of validation—winning against global alternatives. Pixxel won NASA contracts because their hyperspectral imaging is world-class. ideaForge won head-to-head trials against Israeli drones in Middle East (better battery life, 40% cheaper).

    Meril has CE Mark (Europe) and exports cardiac stents to 100+ countries. Waaree exports 40% of production, competing with Chinese manufacturers in the US. GreyOrange won Walmart, IKEA, DHL contracts by matching performance and undercutting 30-40% on price.

    What export wins prove: Product quality meets global standards. Indian cost advantage translates to 30-50% price advantage. 'Made in India' no longer means 'cheap knock-off'—it means 'quality at value pricing.'

    Why This is a 'Why Now' Moment

    Pre-2018: No deep tech IPOs, few ₹100+ Cr revenue companies, minimal exports, Tier-1 VCs skeptical. 2018-2020: Inflection—GreyOrange, Ather, ideaForge crossing ₹100 Cr. PLI schemes announced. COVID supply chain shock made India opportunity clear.

    2020-2024: Validation—multiple ₹1,000+ Cr companies, 3 IPOs, global exports, Tier-1 VC capital flowing in. Deep tech startups grew 3x in India over the past 3 years.

    2025-2030: Scale—5-10 more IPOs expected, ₹50,000 Cr+ exports, global competitiveness proven. The proof exists. The model works. The question: Who's backing the next generation of deep tech founders at TRL 4-5 where they need capital most? That's what we do.

    Founders: Pitch to us